Bluebird Bio competitors and similar companiesClear all
Bluebird Bio's competitors and similar companies include Tanvex Biopharma, H3 Biomedicine, G1 Therapeutics, Ionis Pharmaceuticals, Genprex and Bellicum Pharmaceuticals.
 Tanvex Biopharma Tanvex Biopharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. |  G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. |  Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. |  Bellicum Pharmaceuticals Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies. | ||||
Founding Date | Founding Date 1992 | Founding Date 2013 | Founding Date 2011 | Founding Date 2008 | Founding Date 1989 | Founding Date 2009 | Founding Date 2004 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||
Locations | Locations New Taipei City, TW HQ Irvine, US San Diego, US San Diego, US | Locations Cambridge, US HQ | Locations Durham, US HQ | Locations Carlsbad, US HQ | Locations West Lake Hills, US HQ Austin, US | Locations Houston, US HQ Houston, US Houston, US South San Francisco, US | |
Employees | Employees 1,2134% increase | Employees 1487% decrease | Employees 4116% decrease | Employees 12217% increase | Employees 7577% decrease | Employees 814% increase | Employees 10738% decrease |
Valuation ($) | Valuation ($) 436.8 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 287.4 m | Valuation ($) 5.6 b | Valuation ($) 64.5 m | Valuation ($) 10.9 m |
Twitter followers | Twitter followers 10.5 k | Twitter followers N/A | Twitter followers 476 | Twitter followers 1.3 k | Twitter followers 4.3 k | Twitter followers 2.1 k | Twitter followers 583 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 12 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) 11 | Number of tweets (last 30 days) 8 | Number of tweets (last 30 days) 4 | Number of tweets (last 30 days) 1 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 5.8 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1.8 | Average likes per tweet (last 30 days) 6.4 | Average likes per tweet (last 30 days) 8.8 | Average likes per tweet (last 30 days) 2 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 63.64% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 438682 | Alexa Website Rank 309617 | Alexa Website Rank 324558 | Alexa Website Rank 411905 | Alexa Website Rank 333062 | Alexa Website Rank 386998 | Alexa Website Rank 421105 |
Employee Rating | Employee Rating 3.6 | Employee Rating 3.2 | Employee Rating 3.6 | Employee Rating 3.4 | Employee Rating 3.6 | Employee Rating N/A | Employee Rating 2.7 |
Financial | |||||||
Revenue (est.) | Revenue (est.) $3.7m (FY, 2021) | Revenue (est.) NT$5.4m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $31.5m (FY, 2021) | Revenue (est.) $810.5m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods NT$1.9m (FY, 2021) | Cost of goods N/A | Cost of goods N/A | Cost of goods $10.8m (FY, 2021) | Cost of goods N/A | Cost of goods N/A |
Net income | Net income ($819.4m) (FY, 2021) | Net income (NT$1.5b) (FY, 2021) | Net income N/A | Net income ($148.4m) (FY, 2021) | Net income ($28.6m) (FY, 2021) | Net income ($19.6m) (FY, 2021) | Net income ($9.7m) (FY, 2021) |
Operating ⚠ | |||||||
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 40 (FY, 2020) | Patents (US) 161 (Jun, 2021) | Patents (US) N/A | Patents (US) N/A |
Patents and Patent Applications | Patents and Patent Applications 1.2 k (FY, 2020) | Patents and Patent Applications N/A | Patents and Patent Applications N/A | Patents and Patent Applications 350 (FY, 2020) | Patents and Patent Applications N/A | Patents and Patent Applications N/A | Patents and Patent Applications N/A |
Funding | |||||||
Total funding raised | Total funding raised $ 409m | Total funding raised $ 346.9m | Total funding raised $ 200m | Total funding raised $ 289.6m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Tanvex Biopharma
HQ
New Taipei City, TW
Employees
148↓ 7% decrease
Tanvex Biopharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
View company
H3 Biomedicine
HQ
Cambridge, US
H3 Biomedicine is a biopharmaceutical company that specializes in cancer genomics.
View companyG1 Therapeutics
HQ
Durham, US
Employees
122↑ 17% increase
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
View companyIonis Pharmaceuticals
HQ
Carlsbad, US
Employees
757↓ 7% decrease
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View company